Precision Medicine for Pancreas Cancer Treatment: A Multidisciplinary Challenge or Opportunity?
- 11 January 2023
- journal article
- editorial
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 21 (11) , 2740-2742
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Comparison of endoscopic ultrasound tissue acquisition methods for genomic analysis of pancreatic cancerJournal of Gastroenterology and Hepatology, 2018
- Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor InitiativeClinical Cancer Research, 2018
- A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal AdenocarcinomaAnnals of Surgery, 2018
- Utility of Endoscopic Ultrasound-Guided Biopsy for Next-Generation Sequencing of Pancreatic Exocrine MalignanciesPancreas, 2018
- Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision MedicineCancer Discovery, 2018
- Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS TrialClinical Cancer Research, 2018
- Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignanciesLaboratory Investigation, 2017
- Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) TrialClinical Cancer Research, 2015
- Characterization of Endoscopic Ultrasound Fine-Needle Aspiration Cytology by Targeted Next-Generation Sequencing and Theranostic PotentialClinical Gastroenterology and Hepatology, 2015
- Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic CancerGastroenterology, 2009